Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Non-Current Debt (2017 - 2022)

Inspire Medical Systems (INSP) has disclosed Non-Current Debt for 6 consecutive years, with $9.8 million as the latest value for Q2 2022.

  • Quarterly Non-Current Debt fell 55.07% to $9.8 million in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $9.8 million through Jun 2022, down 55.07% year-over-year, with the annual reading at $15.8 million for FY2021, 36.16% down from the prior year.
  • Non-Current Debt hit $9.8 million in Q2 2022 for Inspire Medical Systems, down from $12.8 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $24.9 million in Q4 2018 to a low of $9.8 million in Q2 2022.
  • Historically, Non-Current Debt has averaged $22.0 million across 5 years, with a median of $24.4 million in 2019.
  • Biggest five-year swings in Non-Current Debt: soared 51.43% in 2018 and later plummeted 55.07% in 2022.
  • Year by year, Non-Current Debt stood at $24.9 million in 2018, then decreased by 1.62% to $24.5 million in 2019, then rose by 0.91% to $24.7 million in 2020, then tumbled by 36.16% to $15.8 million in 2021, then tumbled by 38.0% to $9.8 million in 2022.
  • Business Quant data shows Non-Current Debt for INSP at $9.8 million in Q2 2022, $12.8 million in Q1 2022, and $15.8 million in Q4 2021.